+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novartis AG - logo

Novartis is a global healthcare company based in Basel, Switzerland. They have created a patient-centered portfolio consisting of a wide range of products and treatments to address unmet medical needs. Novartis focuses its business on three leading divisions: pharmaceuticals, eye care and generics. They are expanding their presence in the emerging markets of Asia, Africa and Latin America, where there is fast-growing demand for access to high-quality medicines and healthcare.

Nucleic Acid Testing - Global Strategic Business Report - Product Thumbnail Image

Nucleic Acid Testing - Global Strategic Business Report

  • Report
  • November 2024
  • 372 Pages
  • Global
From
From
Malignant Mesothelioma - Global Strategic Business Report - Product Thumbnail Image

Malignant Mesothelioma - Global Strategic Business Report

  • Report
  • November 2024
  • 193 Pages
  • Global
From
Immuno-Oncology - Global Strategic Business Report - Product Thumbnail Image

Immuno-Oncology - Global Strategic Business Report

  • Report
  • November 2024
  • 224 Pages
  • Global
From
Vitamin D Therapy - Global Strategic Business Report - Product Thumbnail Image

Vitamin D Therapy - Global Strategic Business Report

  • Report
  • November 2024
  • 92 Pages
  • Global
From
Global Esophageal Squamous Cell Carcinoma - Pipeline Insight, 2022 - Product Thumbnail Image

Global Esophageal Squamous Cell Carcinoma - Pipeline Insight, 2022

  • Clinical Trials
  • August 2022
  • 150 Pages
  • Global
From
From
From
From
Liver Cancer Drugs Market 2024-2028 - Product Thumbnail Image

Liver Cancer Drugs Market 2024-2028

  • Report
  • June 2024
  • 142 Pages
  • Global
From
Over-The-Counter (OTC) Analgesics Market 2024-2028 - Product Thumbnail Image

Over-The-Counter (OTC) Analgesics Market 2024-2028

  • Report
  • May 2024
  • 171 Pages
  • Global
From
Kidney Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Kidney Cancer Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 148 Pages
  • Global
From
Loading Indicator